Cubist Systematic Strategies’s Emergent Biosolutions EBS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-198,373
Closed -$1.9M 1673
2024
Q4
$1.9M Sell
198,373
-132,107
-40% -$1.26M 0.01% 611
2024
Q3
$2.76M Buy
330,480
+310,760
+1,576% +$2.59M 0.02% 545
2024
Q2
$134K Sell
19,720
-21,668
-52% -$148K ﹤0.01% 1138
2024
Q1
$105K Sell
41,388
-461,851
-92% -$1.17M ﹤0.01% 1806
2023
Q4
$1.21M Buy
503,239
+163,545
+48% +$393K 0.01% 1018
2023
Q3
$1.15M Buy
339,694
+181,879
+115% +$618K 0.01% 989
2023
Q2
$1.16M Sell
157,815
-5,898
-4% -$43.4K 0.01% 1113
2023
Q1
$1.7M Buy
163,713
+42,748
+35% +$443K 0.01% 1206
2022
Q4
$1.43M Buy
120,965
+17,549
+17% +$207K 0.01% 1524
2022
Q3
$2.17M Buy
103,416
+82,227
+388% +$1.73M 0.01% 1519
2022
Q2
$658K Sell
21,189
-63,424
-75% -$1.97M ﹤0.01% 2420
2022
Q1
$3.47M Sell
84,613
-16,323
-16% -$670K 0.03% 1029
2021
Q4
$4.39M Buy
100,936
+86,046
+578% +$3.74M 0.04% 750
2021
Q3
$746K Sell
14,890
-31,406
-68% -$1.57M 0.01% 1746
2021
Q2
$2.92M Buy
46,296
+26,740
+137% +$1.68M 0.03% 850
2021
Q1
$1.82M Buy
19,556
+6,113
+45% +$568K 0.02% 1103
2020
Q4
$1.2M Sell
13,443
-42,125
-76% -$3.77M 0.02% 1257
2020
Q3
$5.74M Buy
55,568
+52,150
+1,526% +$5.39M 0.09% 346
2020
Q2
$270K Sell
3,418
-17,019
-83% -$1.34M ﹤0.01% 1891
2020
Q1
$1.18M Sell
20,437
-6,075
-23% -$351K 0.03% 732
2019
Q4
$1.43M Sell
26,512
-2,738
-9% -$148K 0.03% 938
2019
Q3
$1.53M Buy
29,250
+18,517
+173% +$968K 0.03% 760
2019
Q2
$519K Buy
+10,733
New +$519K 0.01% 1450
2019
Q1
Sell
-6,654
Closed -$394K 2286
2018
Q4
$394K Buy
+6,654
New +$394K 0.02% 1101
2018
Q3
Sell
-4,626
Closed -$234K 1913
2018
Q2
$234K Sell
4,626
-247
-5% -$12.5K 0.01% 1241
2018
Q1
$257K Sell
4,873
-8,322
-63% -$439K 0.02% 1250
2017
Q4
$613K Buy
13,195
+7,407
+128% +$344K 0.03% 760
2017
Q3
$234K Buy
+5,788
New +$234K 0.01% 1340
2017
Q1
Sell
-18,077
Closed -$594K 1676
2016
Q4
$594K Buy
+18,077
New +$594K 0.05% 589
2016
Q3
Sell
-12,912
Closed -$363K 1730
2016
Q2
$363K Buy
12,912
+7,386
+134% +$208K 0.02% 964
2016
Q1
$201K Buy
+5,526
New +$201K 0.01% 1218